Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone

Acta Dermato-Venereologica

Volumn 85, Issue 3, 2005, Pages 233-235

  Martínez De Pablo, María Isabel ^a,c   Iranzo, Pilar ^a   Mascaró, José Manuel ^a   Llambrich, Alex ^a   Baradad, Manel ^b   Herrero, Carmen ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Bullous disease; Lymphoma; Paraneoplastic; Therapy

Indexed keywords

CHLORAMBUCIL; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ACANTHOLYSIS; AGED; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BLISTER; BONE MARROW TOXICITY; BULLOUS SKIN DISEASE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHODGKIN LYMPHOMA; PANCYTOPENIA; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PRIORITY JOURNAL; PROGNOSIS; STOMATITIS;

AGED; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; LYMPHOMA, B-CELL; ORAL ULCER; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; PREDNISONE;

EID: 18844447209     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550510025542     Document Type: Article

References (21)

1. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-1735.
2. Horn TD, Anhalt GJ. Histologic features of paraneoplastic pemphigus. Arch Dermatol 1991; 128: 1091-1095.
3. Liu AY, Valenzuela R, Helm TN, Camisa C, Melton AL, Bergfeld WF. Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol 1993; 28: 696-699.
4. Helou J, Allbritton J, Anhalt GJ. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 1995; 32: 441-447.
5. Joly P, Richard C, Gilbert D, Courville P, Chosidow O, Roujeau JC, et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000; 43: 619-626.
6. Mahoney MG, Aho S, Uitto J, Stanley JR. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 1998; 111: 308-313.
7. Hashimoto T, Amagai M, Watanabe K, Chorzelskl TP, Bhogal BS, Black MM, et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995; 104: 829-834.
8. Chiewchanvit S, Hashimoto T, Chaiwun B, Nishikawa T. A pemphigus case with long-term survival, implicating the spectrum between paraneoplastic pemphigus and pemphigus vulgaris. Int J Dermatol 1997; 36: 957-958.
9. Lam S, Stone MS, Goeken JA. Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatodactyly in a patient with bronchogenic squamous cell carcinoma. Ophthalmology 1992; 20: 1001-1004.
10. Krunic AL, Kokai D, Bacetic B, Kesik V, Nickolic MM, Petkovic S, et al. Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption. Int J Dermatol 1997; 36: 526-529.
11. Bowen GM, Peters NT, Fivenson DP, Su LD, Noussari HC, Anhalt GJ, et al. Lichenoid dermatitis in paraneoplastic pemphigus. A pathogenic trigger of epitope spreading? Arch Dermatol 2000; 136: 652-656.
12. Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome. Arch Dermatol 2001; 137: 193-207.
13. Sun H, Wang R, Bin H, Wang Y, Jiang X, Na J, et al. Localized Castlemans disease with paraneoplastic pemphigus and pulmonary involvement: clinical features and histopathology. Nat Med J China 2002; 82: 530.
14. Martel P, Loiseau P, Joly P, Busson M, Lepage V, Mouquet H, et al. Paraneoplastic pemphigus is associated with the DRB1*03 allele. J Autoimmunity 2003; 20: 91-95.
15. Camisa C, Helm TN, Liu YC, Valenzuela R, Allen C, Bona S, et al. Paraneoplastic pemphigus: a report of three cases including one long-term survivor. J Am Acad Dermatol 1992; 27: 547-553.
16. Noussari HC, Deterding R, Wojtczack H, Aho S, Uitto J, Hashimoto T, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999; 340: 1406-1411.
17. Perniciaro C, Kuechle MK, Colón-Otero G, Raymond MG, Spear KL, Pittelkow MR. Paraneoplastic pemphigus: a case of prolonged survival. Mayo Clin Proc 1994; 69: 851-855.
18. Noussari HC, Brodsky RA, Jones RJ, Grever MR, Anhalt GJ. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol 1999; 40: 750-754.
19. Heinzmann M, Itin P, Wernli M, Borradori L, Bargetzi MJ. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001; 66: 142-144.
20. Dega H, Laporte JL, Joly P, Gabarre J, André C. Paraneoplastic pemphigus associated with Hodgkins disease. Br J Dermatol 1998; 138: 196-198.
21. Beutner EH, Pelton S, Hashimoto T, Xu Y, Plunkett RW, Korman NJ, et al. A nonfatal case and 2 fatal cases of paraneoplastic pemphigus: can complement indirect immunofluorescent test help to identify fatal "group A" paraneoplastic pemphigus cases? J Am Acad Dermatol 2002; 47: 841-851.